๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Vellore
Clinical trial register · India

Clinical Trials in Vellore

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals5 Genzyme, a Sanofi Company3 Takeda2 Sanofi2 Azafaros B.V.2
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
31 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT07422480Myelodysplastic Syndrome, Anemia
Takeda
Phase 3
300
Kochi, Pune, Vellore, Hyderabad, Chandigarh, Delhi
2026-05-21
Recruiting
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
NCT07285460Hemophilia
Sanofi
Phase 3
85
Bengaluru, Mumbai, Pune, Vellore
2025-12-18
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
NCT07225504Secondary Progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals
Phase 3
1,275
Gurugram, Mangalore, Kochi, New Delhi, Chandigarh, Vellore, Hyderabad
2025-11-11
Recruiting
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
NCT07082725Niemann-Pick Type C Disease
Azafaros B.V.
Phase 3
72
Ernฤkulam, New Delhi, Jaipur, Vellore
2025-06-30
Recruiting
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
NCT07054515Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis
Azafaros B.V.
Phase 3
147
Ernฤkulam, New Delhi, Jaipur, Vellore
2025-06-30
Recruiting
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
NCT06862219Metastatic Urothelial Carcinoma
Astellas Pharma Global Development, Inc.
Phase 4
100
Patna, Kochi, Mumbai, New Delhi, Dumas, Vellore, Varanasi, Kolkata
2025-06-21
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT06499285Myelodysplastic Syndromes
Takeda
Phase 3
225
Ahmedabad, Ernฤkulam, Mumbai, New Delhi, Ludhiana, Vellore, Ghaziabad, Kolkata
2025-05-06
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
4,000
Bengaluru, Chennai, Vellore
2025-03-01
Recruiting
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
NCT06744920Generalized Myasthenia Gravis
Novartis Pharmaceuticals
Phase 3
180
Gurugram, Mangalore, Nashik, New Delhi, Ludhiana, Vellore, Hyderabad, Lucknow
2025-02-07
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
NCT06750094Colorectal Neoplasms
Janssen Research & Development, LLC
Phase 3
700
Delhi, Hyderabad, Kolkata, Mumbai, New Delhi, Pune, Varanasi, Vellore
2024-12-12
Recruiting
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
NCT06080789Acute Pancreatitis
Panafina, Inc.
Phase 2
36
Kochi, Vellore, Chandigarh, Delhi, New Delhi
2024-06-28
Recruiting
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
NCT05935358Severe Hemophilia A
Octapharma
Phase 4
28
Vellore, Bengaluru
2023-11-28
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Hyderabad, Chandigarh, Faridabad, Bengaluru, Trivandrum, Jaipur, Vellore, Lucknow
2023-07-06
Recruiting
Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System
NCT04861805Symptomatic Aortic Stenosis
P+F Products + Features GmbH
Not applicable
267
Bangalore, Gurgaon, Jaipur, Kochi, Vellore
2023-07-03
Active, closed
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia
NCT05662319Hemophilia
Sanofi
Phase 3
91
Bangalore, Bhubaneswar, Pune-411011, Punjab, Vellore
2023-02-01
Active, closed
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
NCT05620407Systemic Lupus Erythematosus
Bristol-Myers Squibb
Phase 3
513
Ahmedabad, Hubli, Mysore, Nagpur, Vellore, Hyderabad, Secundarabad
2023-01-12
Active, closed
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
NCT05501886Breast Cancer
Celcuity Inc
Phase 3
701
Jaipur, Bangalore, Chandigarh, Kolkata, Navi Mumbai, Vellore
2022-12-08
Active, closed
An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
NCT05626387Hypersensitivity Pneumonitis
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
144
Chandigarh, Hyderabad, Jaipur, Jodhpur, Lucknow, New Delhi, Rishikesh, Vellore
2022-11-23
Recruiting
International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery
NCT05673499Congenital Disorders, Cerebral Desaturation, Neonatal Surgery
Children's Hospital of Philadelphia
Observational
900
Chandigarh, Vellore
2022-08-12
Recruiting
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
NCT05268289Lupus Nephritis
Novartis Pharmaceuticals
Phase 2
240
Ahmedabad, Kozhikode, New Delhi, Vellore, Hyderabad, Lucknow, Puducherry
2022-08-10
Recruiting
PRISMA Maternal and Newborn Health Study
NCT05904145Pregnancy, High Risk
George Washington University
Observational
267,897
Vellore
2022-08-01
Recruiting
Transcriptomic Responses for the Identification of Pathogens
NCT04878549Enteric Fever, Acute Febrile Illness, Typhoid, Paratyphoid Fever
University of Sheffield
Observational
2,000
Vellore
2022-05-02
Recruiting
Rapid Research in Diagnostics Development for TB Network
NCT04923958Tuberculosis
University of California, San Francisco
Not applicable
26,436
Vellore
2021-04-14
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
404
Kozhikode, Pune, Vellore, Hyderabad, Secunderabad, Kolkata
2020-12-11
Active, closed
A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)
NCT03992430Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc.
Phase 3
160
Ahmedabad, Bengaluru, Hyderabad, Madurai, New Delhi, Pune, Vellore
2020-07-13
Rows per page Showing 1–25 of 31
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/vellore

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.